![Zhan Chao Liang](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Zhan Chao Liang
Chief Investment Officer bij Shanghai Med-Fine Asset Management Co. Ltd.
Profiel
Zhan Chao Liang is currently the Director at Beijing Mabworks Biotech Co., Ltd.
and the Chief Investment Officer & Partner at Shanghai Med-Fine Asset Management Co. Ltd.
He completed his undergraduate degree from Hlj August First Land Reclamation University in 2008 and his graduate degree from the Academy of Military Medical Sciences in 2011.
Actieve functies van Zhan Chao Liang
Bedrijven | Functie | Begin |
---|---|---|
Beijing Mabworks Biotech Co., Ltd.
![]() Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | Directeur/Bestuurslid | 01-05-2016 |
Shanghai Med-Fine Asset Management Co. Ltd. | Chief Investment Officer | 01-04-2015 |
Opleiding van Zhan Chao Liang
Hlj August First Land Reclamation University | Undergraduate Degree |
Academy of Military Medical Sciences | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Beijing Mabworks Biotech Co., Ltd.
![]() Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | Health Technology |
Shanghai Med-Fine Asset Management Co. Ltd. |